Your browser doesn't support javascript.
loading
Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective.
Zhang, Yongsheng; Liang, Xinjie; Bao, Xuefei; Xiao, Wei; Chen, Guoliang.
Afiliação
  • Zhang Y; Key Laboratory of Structure-Based Drugs Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China.
  • Liang X; Key Laboratory of Structure-Based Drugs Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China.
  • Bao X; Jiangsu Kanion Pharmaceutical Co.,Ltd., Lianyungang, China; Key Laboratory of Structure-Based Drugs Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China. Electronic address: bxf551@163.com.
  • Xiao W; Jiangsu Kanion Pharmaceutical Co.,Ltd., Lianyungang, China. Electronic address: xw_kanion@163.com.
  • Chen G; Key Laboratory of Structure-Based Drugs Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China. Electronic address: spucgl@163.com.
Eur J Med Chem ; 235: 114291, 2022 May 05.
Article em En | MEDLINE | ID: mdl-35307617
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno 96 de Linfócito / Receptor 4 Toll-Like Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno 96 de Linfócito / Receptor 4 Toll-Like Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article